08511
姜黄素
analytical standard
别名:
(E,E)-1,7-双(4-羟基-3-甲氧基苯基)-1,6-庚二烯-3,5-二酮, 二阿魏酸甲烷, 天然黄3
登录 查看组织和合同定价。
选择尺寸
关于此项目
线性分子式:
[HOC6H3(OCH3)CH=CHCO]2CH2
化学文摘社编号:
分子量:
368.38
UNSPSC Code:
85151701
NACRES:
NA.24
E Number:
E100
PubChem Substance ID:
EC Number:
207-280-5
MDL number:
Colour Index Number:
75300
Beilstein/REAXYS Number:
2306965
产品名称
姜黄素, analytical standard
InChI key
VFLDPWHFBUODDF-FCXRPNKRSA-N
InChI
1S/C21H20O6/c1-26-20-11-14(5-9-18(20)24)3-7-16(22)13-17(23)8-4-15-6-10-19(25)21(12-15)27-2/h3-12,24-25H,13H2,1-2H3/b7-3+,8-4+
SMILES string
COc1cc(\C=C\C(=O)CC(=O)\C=C\c2ccc(O)c(OC)c2)ccc1O
grade
analytical standard
vapor density
13 (vs air)
assay
≥98.0% (HPLC)
form
powder
shelf life
limited shelf life, expiry date on the label
technique(s)
HPLC: suitable
gas chromatography (GC): suitable
application(s)
cleaning products
cosmetics
food and beverages
personal care
format
neat
storage temp.
2-8°C
Quality Level
正在寻找类似产品? 访问 产品对比指南
Application
姜黄素可作为高效液相色谱法测定大鼠血浆中姜黄素含量的参考标准品。
Biochem/physiol Actions
一种天然酚类化合物。它是有效的抗肿瘤剂，具有抗炎和抗氧化活性。除了具有化疗活性外，姜黄素还被认为是潜在的化学预防剂。它能够诱导癌细胞凋亡并抑制佛波酯诱导的蛋白激酶C（PKC）活性。据报道，它能抑制外周血单核细胞和肺泡巨噬细胞产生炎性细胞因子。它是EGFR酪氨酸激酶和IκB激酶的有效抑制剂。它能抑制诱导型一氧化氮合酶（iNOS）、环加氧酶和脂氧合酶。它易于渗透到细胞质中，在质膜、内质网和核膜等膜结构中积累。
它是一种天然酚类化合物，是姜黄的黄色来源。它是有效的抗肿瘤剂，作用于高度多样化的肿瘤特异性通路。它具有抗炎和抗氧化活性。它能够诱导癌细胞凋亡并抑制佛波酯诱导的蛋白激酶C（PKC）活性。据报道，它能抑制外周血单核细胞和肺泡巨噬细胞产生炎性细胞因子。它是EGFR酪氨酸激酶和IκB激酶的有效抑制剂。它能抑制诱导型一氧化氮合酶（iNOS）、环加氧酶（COX-2）和5-脂氧合酶（5-LOX）。
General description
姜黄素是一种抗炎剂，提取自姜黄的根部。
Other Notes
这种化合物通常存在于蓍属植物中：姜黄属
Packaging
无底玻璃瓶。内含物装在插入的融合锥内。
存储类别
11 - Combustible Solids
wgk
WGK 3
flash_point_f
Not applicable
flash_point_c
Not applicable
Phase I clinical trial of curcumin, a chemopreventive agent, in patients with highrisk or pre-malignant lesions.
Hsieh CY.
Anticancer Research, 21, 2895-2900 (2001)
A rapid and simple HPLC method for the determination of curcumin in rat plasma: assay development, validation and application to a pharmacokinetic study of curcumin liposome.
Li J, et al.
Biomedical Chromatography, 23(11), 1201-1207 (2009)
Oxygen radical scavenging activity of curcumin.
Kunchandy E and Rao MNA
International Journal of Pharmaceutics, 58(3), 237-240 (1990)
Michal Heger et al.
Pharmacological reviews, 66(1), 222-307 (2013-12-26)
This review addresses the oncopharmacological properties of curcumin at the molecular level. First, the interactions between curcumin and its molecular targets are addressed on the basis of curcumin's distinct chemical properties, which include H-bond donating and accepting capacity of the
Wing-Hin Lee et al.
Expert opinion on drug delivery, 11(8), 1183-1201 (2014-05-27)
Natural compounds are emerging as effective agents for the treatment of malignant diseases. Curcumin (diferuloylmethane), the active constituent of turmeric extract, has gained significant interest as a plant-based compound with anti-cancer properties. Curcumin is physiologically very well tolerated, with negligible
我们的科学家团队拥有各种研究领域经验，包括生命科学、材料科学、化学合成、色谱、分析及许多其他领域.
联系客户支持